stockrowRadNet, Inc.
RDNT Healthcare Diagnostics & Research
RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024.
- Revenue
- +25.0%
- EPS
- −47.4%
- Free cash flow
- −43.2%
- Total debt
- +21.2%
Quarter to June 2026, against a year earlier
Follow RDNT
Alert me
RadNet, Inc. (RDNT) Revenue growth
RadNet, Inc.'s revenue growth over the twelve months to 30 June 2026 was 18.9%, up 7.4 percentage points from fiscal 2025 (11.5%). Over the past ten years it has ranged from −7.13% (fiscal 2020) to 22.7% (fiscal 2021); the current reading is higher than 55% of that period. That is above the Diagnostics & Research industry median of 8.99% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 11.5% | (1.67) |
| FY2024 | 13.2% | 0.13 |
| FY2023 | 13.1% | 4.31 |
| FY2022 | 8.74% | (13.95) |
| FY2021 | 22.7% | 29.82 |
| FY2020 | −7.13% | (25.49) |
| FY2019 | 18.4% | 12.62 |
| FY2018 | 5.74% | 1.48 |
| FY2017 | 4.26% | (4.99) |
| FY2016 | 9.25% | (3.58) |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 25.0% | 2.88 |
| Mar 2026 | 22.1% | 7.31 |
| Dec 2025 | 14.8% | 1.41 |
| Sep 2025 | 13.4% | 5.01 |
| 42 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| BLLN BillionToOne, Inc. compare | 76.5% |
| CDNA CareDx, Inc. compare | 38.9% |
| RDNT RadNet, Inc. | 18.9% |
| ADPT Adaptive Biotechnologies Corporation compare | 17.9% |
| VCYT Veracyte, Inc. compare | 17.5% |
| GRAL GRAIL, Inc. compare | 17.5% |
| SHC Sotera Health Company compare | 6.90% |
| QGEN QIAGEN N.V. compare | 2.96% |
| ICLR ICON PLC compare | 1.82% |
| Diagnostics & Research industry median | 8.99% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on RDNT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement